Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 53 min ago
Peer-reviewedLicence not statedHematology/Oncology Clinics of North America

Evolution of Precision Oncology, Personalized Medicine, and Molecular Tumor Boards

  • Yu Fujiwara1,2
  • Shumei Kato3
  • Razelle Kurzrock4
4 affiliations
  1. 1Department of Clinical Oncology, Institute of Science Tokyo, Tokyo, Japan. Electronic address: [email protected]
  2. 2Department of Medicine, Roswell Park Comprehensive Cancer Center, Elm and Carlton Streets, Buffalo, NY 14263, USA. Electronic address: [email protected]
  3. 3Center for Personalized Cancer Therapy, University of California San Diego Moores Cancer Center, 3855 Health Sciences Drive, La Jolla, CA 92093, USA; Division of Hematology and Oncology, Department of Medicine, University of California San Diego Moores Cancer Center, La Jolla, CA, USA
  4. 4Genomic Sciences and Precision Medicine Center, Medical College of Wisconsin, Froedtert and Medical College of Wisconsin Cancer Center and Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine, 9200 West Wisconsin Avenue, Milwaukee, WI 53226, USA; WIN Consortium, Paris, France; University of Nebraska, Lincoln, NE, USA
Open at sourceDOICite

Related

  1. Clinical Translation of Artificial Intelligence in Oncology: Real-World Validation, Workflow Integration, and Precision Medicine Applications
    Ohmini Krishnamurthy Rajendran
    International Journal of Drug Delivery TechnologyPeer-reviewedLicence not statedFull text20 citedEpidemiology & public healthOpenAlex
  2. Real-World Evidence as a Driver of Precision Oncology and Personalized Therapeutic Sequencing in Later-Line Metastatic Colorectal Cancer
    Carlo Signorelli
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  3. Precision Medicine in Acute Coronary Syndromes: Integrating Plaque Phenotyping, Personalized Revascularization, Antithrombotic Strategies, and Residual Risk Reduction
    Ahmad Omari, Yazeed Omari, Ahmad Kharoufeh +7
    Journal of Clinical MedicinePeer-reviewedCC BY 4.0Surgery & anaesthesiaCrossref
  4. From cytoreduction to precision oncology: evolution of ovarian cancer therapy.
    Ghassan M Saed, Laura Detti, Dina Massad +2
    Journal of ovarian researchPeer-reviewedCC BY-NC-NDFull textObstetrics, gynaecology & paediatricsEurope PMCDOAJ
  5. The promise and limits of patient-reported outcomes in molecular tumor board-guided care: toward a framework for patient-centered precision oncology.
    L Gräßel, S Yacob, C Strantz +12
    NPJ precision oncologyPeer-reviewedCC BYFull textOncologyEurope PMCPMC

Cite

BibTeXRIS
BibTeX
@article{fujiwara2026evolution,
  title = {{Evolution of Precision Oncology, Personalized Medicine, and Molecular Tumor Boards}},
  author = {Yu Fujiwara and Shumei Kato and Razelle Kurzrock},
  journal = {Hematology/Oncology Clinics of North America},
  year = {2026},
  month = sep,
  doi = {10.1016/j.hoc.2026.05.019},
  url = {https://doi.org/10.1016/j.soc.2023.12.004},
}
RIS
TY  - JOUR
TI  - Evolution of Precision Oncology, Personalized Medicine, and Molecular Tumor Boards
AU  - Yu Fujiwara
AU  - Shumei Kato
AU  - Razelle Kurzrock
PY  - 2026
DA  - 2026/09/02
JO  - Hematology/Oncology Clinics of North America
DO  - 10.1016/j.hoc.2026.05.019
UR  - https://doi.org/10.1016/j.soc.2023.12.004
SN  - 0889-8588
SN  - 1558-1977
ER  -